Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 17.59 +0.42 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.17 | 52 Week High | $19.75 | |||
| Open | $17.36 | 52 Week Low | $4.26 | |||
| Day High | $17.62 | P/E | N/A | |||
| Day Low | $16.82 | EPS | $0.00 | |||
| Volume | 5,754,954 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.85 -0.36 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.21 | 52 Week High | $63.73 | |||
| Open | $18.25 | 52 Week Low | $8.00 | |||
| Day High | $18.53 | P/E | N/A | |||
| Day Low | $17.68 | EPS | $-5.69 | |||
| Volume | 3,015,057 | |||||
